Literature DB >> 19285925

Determination of lumefantrine in rat plasma by liquid-liquid extraction using LC-MS/MS with electrospray ionization: assay development, validation and application to a pharmacokinetic study.

Sheelendra Pratap Singh, Girish Kumar Jain.   

Abstract

A simple, sensitive and rapid method for the analysis of lumefantrine in rat plasma using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) was developed. Detection was performed by positive ion electrospray ionization (ESI) in multiple reaction monitoring (MRM) mode. The method included a chromatographic run of 5 min using a C(18) analytical column and the calibration curve was linear over the concentration range of 2-500 ng/mL with a correlation coefficient (r) of 0.996 or better. The intra- and inter-day assay precision ranged from 1.5 to 7.5% and 5.5 to 7.7%, respectively, and intra- and inter-day assay accuracy was between 91.3-109.7% and 97.0-104.7%, respectively. The method was successfully applied for the pharmacokinetic study in rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285925     DOI: 10.1016/j.jchromb.2009.02.058

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Determination of lumefantrine in small-volume human plasma by LC-MS/MS: using a deuterated lumefantrine to overcome matrix effect and ionization saturation.

Authors:  Liusheng Huang; Xiaohua Li; Florence Marzan; Patricia S Lizak; Francesca T Aweeka
Journal:  Bioanalysis       Date:  2012-01       Impact factor: 2.681

2.  Investigation of the functional role of P-glycoprotein in limiting the oral bioavailability of lumefantrine.

Authors:  Kanumuri S R Raju; Sheelendra P Singh; Isha Taneja
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

3.  Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats.

Authors:  Sheelendra P Singh; Kanumuri S R Raju; Asad Nafis; Sunil K Puri; Girish K Jain
Journal:  Malar J       Date:  2011-10-10       Impact factor: 2.979

4.  Simultaneous quantification of proposed anti-malarial combination comprising of lumefantrine and CDRI 97-78 in rat plasma using the HPLC-ESI-MS/MS method: application to drug interaction study.

Authors:  Muhammad Wahajuddin; Sheelendra P Singh; Isha Taneja; Kanumuri S R Raju; Jiaur R Gayen; Hefazat H Siddiqui; Shio K Singh
Journal:  Malar J       Date:  2015-04-22       Impact factor: 2.979

5.  Quantification of Lumefantrine in Human Plasma Using LC-MS/MS and Its Application to a Bioequivalence Study.

Authors:  Satish G Pingale; Kiran V Mangaonkar
Journal:  J Pharm (Cairo)       Date:  2012-09-23

6.  Assessment of pharmacokinetic compatibility of short acting CDRI candidate trioxane derivative, 99-411, with long acting prescription antimalarials, lumefantrine and piperaquine.

Authors:  Isha Taneja; Kanumuri Siva Rama Raju; Sheelendra Pratap Singh; Muhammad Wahajuddin
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.